PARP inhibitors unleash the antitumor immune response

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Combination of a PARP inhibitor with immune checkpoint blockade showed promising antitumor activity without additional toxicity.

Original languageEnglish (US)
JournalScience translational medicine
Volume12
Issue number559
DOIs
StatePublished - 2020

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'PARP inhibitors unleash the antitumor immune response'. Together they form a unique fingerprint.

Cite this